Tarsus Pharmaceuticals, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $8.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $586.0K | 6.9% |
| Working Capital | $4.7M | 55.5% |
| Net Cash Flow | $3.2M | 37.6% |
Net Cash Flow Breakdown
Total Cash from Operations: $8.5M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $586.0K | 6.9% |
| Working Capital | $4.7M | 55.5% |
| Net Cash Flow | $3.2M | 37.6% |